Additionally, we performed a functional analysis of the NRGs, and our results indicated that these NRGs were involved in platinum drug resistance, bladder cancer, apoptosis, p53 signaling pathway, pancreatic cancer, hepatitis B, erbB signaling pathway, apoptosis-multiple species, IL-17 signaling pathway, and endocrine resistance. The gene discussed is IL17A; the disease is familial pancreatic carcinoma.